TransMedics Group, Inc. (TMDX)
91.37
-0.63
(-0.68%)
USD |
NASDAQ |
Nov 13, 16:00
90.10
-1.27
(-1.39%)
After-Hours: 19:59
TransMedics Group Total Liabilities (Quarterly) : 967.22M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 967.22M |
| June 30, 2026 | 946.34M |
| March 31, 2026 | 940.81M |
| December 31, 2025 | 645.60M |
| September 30, 2025 | 590.83M |
| June 30, 2025 | 572.42M |
| March 31, 2025 | 571.22M |
| December 31, 2024 | 599.83M |
| September 30, 2024 | 575.65M |
| June 30, 2024 | 568.68M |
| March 31, 2024 | 564.36M |
| December 31, 2023 | 568.84M |
| September 30, 2023 | 562.77M |
| June 30, 2023 | 545.14M |
| March 31, 2023 | 94.46M |
| December 31, 2022 | 89.77M |
| September 30, 2022 | 87.02M |
| June 30, 2022 | 66.37M |
| Date | Value |
|---|---|
| March 31, 2022 | 64.10M |
| December 31, 2021 | 67.04M |
| September 30, 2021 | 52.60M |
| June 30, 2021 | 51.53M |
| March 31, 2021 | 48.11M |
| December 31, 2020 | 48.14M |
| September 30, 2020 | 49.77M |
| June 30, 2020 | 49.38M |
| March 31, 2020 | 50.24M |
| December 31, 2019 | 50.65M |
| September 30, 2019 | 49.15M |
| June 30, 2019 | 49.85M |
| March 31, 2019 | 51.28M |
| December 31, 2018 | 47.88M |
| September 30, 2018 | 46.58M |
| June 30, 2018 | 44.27M |
| March 31, 2018 | |
| December 31, 2017 | 19.21M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp. | 19.59B |
| Insulet Corp. | 1.836B |
| Abbott Laboratories | 56.62B |
| Baxter International, Inc. | 12.94B |
| Becton, Dickinson & Co. | 26.11B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.518B |
| Shareholders Equity (Quarterly) | 550.71M |
| Debt to Equity Ratio | 1.574 |
| Current Ratio | 4.530 |
| Net Debt Paydown Yield | -2.40% |